Yelak Biru: The inagural 5-night, 6-day Iceland Cycling Expedition
Yelak Biru, President and Chief Executive Officer at International Myeloma Foundation, shared a post on LinkedIn:
“On Thursday we launched our inagural 5-night, 6-day Iceland Cycling Expedition.
Our journey began with a visit to deCODE genetics headquarters and the iStopMM (Iceland Screens, Treats or Stops Myeloma Study) laboratories. Launched in 2016, iStopMM is a population-based screening study for early detection and intervention of myeloma.
This groundbreaking study boasts the highest participation rate of any clinical trial in a single nation! With over 80,000 individuals (54.2% of Iceland’s population over 40) consenting to be screened, iStopMM is paving the way for advancements in early detection and treatment of myeloma.
International Myeloma Foundation (IMF) is proud to be a seed and ongoing funder of this vital research.
A special thanks to our host, Dr. Sigurdur Yngvi Kristinsson
Stay connected with the IMF and follow the brave participants.”
Source: Yelak Biru/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023